Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01913639
Title FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.